Related Experiment Video
Updated: Jun 21, 2026
06:28
A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
Published on: April 28, 2023
Exercise training reduces circulating adiponectin levels in patients with chronic heart failure
An M Van Berendoncks1, Paul Beckers, Vicky Y Hoymans
1Department of Cardiology, Antwerp University Hospital, 2650 Edegem, Belgium. An.Vanberendoncks@ua.ac.be
Clinical Science (London, England : 1979)
|August 7, 2009
Summary
Exercise training in chronic heart failure (CHF) patients significantly lowers elevated adiponectin levels, a risk factor for poor outcomes. This study demonstrates that physical activity can modulate adiponectin, offering potential therapeutic benefits for CHF management.
Area of Science:
- Cardiology
- Endocrinology
- Exercise Physiology
Background:
- Elevated adiponectin levels are an independent risk factor for adverse outcomes in patients with chronic heart failure (CHF).
- The impact of interventions, such as exercise training, on adiponectin modification in CHF patients remains largely unassessed.
Purpose of the Study:
- To investigate the effect of a structured exercise training program on circulating adiponectin concentrations in patients diagnosed with CHF due to systolic dysfunction.
Main Methods:
- Eighty CHF patients were enrolled; 46 underwent 4 months of exercise training, while 34 served as a sedentary control group.
- Measurements included circulating adiponectin, N-terminal pro-brain natriuretic peptide (NT-proBNP), exercise capacity, and anthropometric data.
- Statistical analysis compared changes in adiponectin between the trained and control groups over the study period.
Main Results:
- CHF patients exhibited significantly higher adiponectin levels compared to healthy individuals.
- Adiponectin concentrations increased progressively with greater disease severity, as indicated by NT-proBNP levels.
- Exercise training led to a significant reduction in adiponectin levels in the trained CHF group, with no change observed in the sedentary group.
Conclusions:
- Circulating adiponectin is elevated in CHF patients and correlates with disease severity.
- A 4-month exercise training program effectively lowers adiponectin levels in CHF patients.
- Exercise training may represent a viable strategy to modulate adiponectin and potentially improve outcomes in chronic heart failure.
Related Concept Videos
01:20Exercise and Cardiovascular Response
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:17Exercise and Cardiac Output
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be met...
Sustained exercise increases the muscles' oxygen demand, which can be met...